<rt id="wow22"><small id="wow22"></small></rt>
<acronym id="wow22"></acronym><rt id="wow22"><small id="wow22"></small></rt>
<rt id="wow22"><small id="wow22"></small></rt>
<rt id="wow22"><optgroup id="wow22"></optgroup></rt><acronym id="wow22"></acronym>
<rt id="wow22"><small id="wow22"></small></rt>
On August 28, 2019, Panax notoginseng was officially launched into the American botanical medicine catalogue (HerbMedPro).?
The publisher:admin     message source:Original    Release time:2020-01-06





It is understood that the Panax notoginseng can enter the United States botanical medicine catalogue, is the American Botanical Council experts on Panax notoginseng related materials after detailed review and demonstration of the consensus. The American Botanical Council is an independent, non-profit research and educational institution dedicated to providing accurate and reliable information to consumers, medical practitioners, researchers, educators, the industry and the media. Through the responsible use of herbs and medicinal plants to help people live a healthier life, it has a strong guiding significance for the application of medicinal plants. 

The breakthrough in this work is closely related to the efforts of the Zeng Lipin team. As the director of Wenshan Panax notoginseng Industry Association, the organizational association and its member units have been committed to the development of Panax notoginseng industry for a long time. Zeng Lipin has strengthened the strength of Panax notoginseng industry in Yunnan by strengthening the standardized management of the association and making suggestions to the competent government departments. At the same time, we should pay attention to the international market and offer suggestions for the Panax notoginseng industry to move towards the national and global market. 

Zeng Lipin has long organized the president, vice president unit Panax notoginseng science and technology, Panlong Yunhai and other industrial leading enterprises, focusing on Panax notoginseng, Panax notoginseng saponins and related products research and development and standard promotion. Organize the Farlong pharmaceutical industry to comprehensively collate the efficacy, pharmacology, safety research and clinical data of Panax notoginseng in the United States. And after rigorous examination by a team of experts composed of American toxicologists, pharmacologists, and plant chemists, they passed the Generally Recognized as Safe (GRAS) safety certification required by the US Food and Drug Administration (FDA). It opened the door for Panax notoginseng saponins to be used as food additives and dietary supplements in the United States market. After that, he contacted the American Botanical Drug Commission and organized a team of experts to review the scientific and clinical data of Panax notoginseng, which was successfully passed and included in the list of botanical drugs in the United States. This means that Panax notoginseng is recognized in the United States as a raw material for plant medicine development and as a food supplement. 

With the opening of the sales threshold of Panax notoginseng and Panax notoginseng saponins in the United States, it not only paves a solid way for the Panax notoginseng industry to move to the international market, but also provides more possibilities for the all-round development of traditional Chinese medicine abroad. To make the international market of Panax notoginseng bigger and stronger, in the near future, the development of Panax notoginseng industry will certainly rise to a new level, so that China's "Panax notoginseng flower" to the world.